The Mutation Profile and Prognosis in AML With IDH1/2 Mutation
Clinical trial NCT07004816 · TERMINATED
Trial details
- NCT number
- NCT07004816
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2017-12-21
- Primary completion
- 2020-03-24
- Enrollment
- 1015
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.